26.05 -0.02 (-0.08%)
After hours: 5:07PM EDT
|Bid||25.02 x 900|
|Ask||26.06 x 3000|
|Day's Range||24.50 - 27.50|
|52 Week Range||13.06 - 29.38|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||26.66|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||28.00|
Alissa Coram, Multimedia Content Editor at Investor's Business Daily, joins Yahoo Finance's Myles Udland and Jared Blikre to break down the price action in these three markets.
LAKE FOREST, Calif. , Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical ...
AT&T;, RH and InMode climbed early Monday. The S&P; 500 and Dow Jones today aimed to add a fourth day to their rallies, and the Nasdaq index eyed a rebound.
Three technology companies, plus a medical-device maker, are showing strong technical momentum. Lattice Semiconductor Corp. (LSCC) gained 53 cents to $19.73 on 1.8 million shares traded Thursday. The move, on no news from the company and following through on Wednesday’s rally, positioned the stock at the top of its five-week sideways channel.
Signals of progress in U.S. China trade talks boosted stock futures Thursday, but can the market break above month-long resistance?
InMode is the IBD Stock Of The Day as the medical aesthetics player rockets 60% above its initial public offering just last month. The market is led by Allergan, soon to merge with AbbVie.
YOQNEAM, Israel, Aug. 27, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, will participate in the 5CC (5 Continent-Congress) in the field of medical and aesthetic dermatology. Drs. Arroyo and Estrada from Spain will be presenting the latest data on Votiva, InMode's breakthrough technology for feminine wellness and genital treatments. In addition, InMode luminaries from the United States, will travel to present their clinical research regarding InMode's minimally invasive and non-invasive aesthetic technologies.
LAKE FOREST, Calif., Aug. 20, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode") announced today the issuance and sale of an additional 500,000 ordinary shares pursuant to the partial exercise of the underwriters' over-allotment option in connection with InMode's initial public offering. The additional shares were sold at the initial offering price of $14.00 per ordinary share, generating additional gross proceeds of approximately $7.0 million and bringing the total gross proceeds to InMode from the offering, before deducting underwriting discounts and commissions and other offering expenses, to approximately $77.0 million.
InMode stock popped for a second day running Thursday after the Paula Abdul-backed medical aesthetics company reported strong revenue growth in the second quarter ended June 30.
Net Income Increased 109% Over Prior Year to $15.8 Million InMode Completed a Successful Initial Public Offering with Gross Proceeds of $70 Million LAKE FOREST, Calif. , Aug. 13, 2019 /PRNewswire/ -- InMode ...
LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- International Pop Icon Paula Abdul has made her mark in this industry as an award-winning dancer and choreographer, singer, actress, and television personality with six number-one singles on the Billboard Hot 100, Emmy and Grammy Awards, and numerous other accolades. Paula has agreed to join InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company") as a brand ambassador to share her positive experience with the Company's BodyTite, FaceTite and Morpheus8 technologies.
LAKE FOREST, Calif., Aug. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode") announced today the closing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The aggregate gross proceeds, before deducting underwriting discounts and commissions and other offering expenses, to InMode from the offering were approximately $70.0 million. Barclays Capital Inc. and UBS Securities LLC acted as the representatives of the underwriters and joint book-running managers for the offering.
LAKE FOREST, Calif., Aug. 7, 2019 /PRNewswire/ -- InMode Ltd. ("InMode"), announced today the pricing of its initial public offering of 5,000,000 ordinary shares at an initial public offering price of $14.00 per ordinary share. The underwriters of the offering will also have a 30-day option to purchase up to an additional 750,000 ordinary shares from InMode at the initial public offering price.
A medical aesthetic company is testing the IPO waters this week. Will investment in the shares give a facelift? The IPO Terms Yokneam, Israel-based Inmode Ltd. has filed with the SEC a preliminary prospectus ...